Monitoring dopamine (DA) levels in biological fluids is highly informative for the early diagnosis and therapeutic management of neurological disorders such as Parkinson’s disease, schizophrenia, attention-deficit/hyperactivity disorder (ADHD), and epilepsy, which represents a major pediatric neurological condition with wide clinical heterogeneity. In this study, we report a preliminary clinical evaluation of an electrochemical sensor developed for DA detection in the blood of pediatric epilepsy…
